Supplement Label Index
Advertisement

Probiotics (Total CFU)

Of 4,150 on-market probiotics (total cfu) products in the January 2026 DSLD dump, the median declared dose is 30,000 CFU.

4,150
on-market products
30,000 CFU
median dose
below RDA
above UL
Advertisement

Form share

Of 0 products with an identifiable primary form, here is the share held by each form of Probiotics (Total CFU) on the market today.

FormQuality tiernShare

Dose distribution

Deciles of declared dose per serving (CFU), among 788 products with a disclosed amount.

p10p20p30p40p50p60p70p80p90Fairy-dust
  • 88.2% of products fall below the fairy-dust threshold (200000000 CFU, 20% of the studied low dose).
  • 71.0% of products don't disclose an amount because Probiotics (Total CFU) is declared inside a proprietary blend.

By dosage form

Capsule 2,455 Powder 928 Tablet or Pill 372 Other (e.g. tea bag) 157 Gummy or Jelly 144 Liquid 45 Softgel Capsule 37 Unknown 6

By target group

Adult (18 - 50 Years) 3,456 Gluten Free 2,735 Dairy Free 2,032 Vegetarian 1,457 Vegan 924 Sugar Free 488 Children 4 or More Years of Age 481 Kosher 339

Top brands

Forms explained

Reference values

  • RDA (adult): not established — Not a DRI nutrient category; no RDA exists.
  • Tolerable Upper Intake Level (adult): not established — Not established. NIH ODS: clinical trials have used doses from roughly 10^7 to 10^11 CFU/day across strains/indications with no established outer ceiling for healthy adults; safety is more a function of strain and host immune status (e.g. caution in immunocompromised individuals) than total CFU count.
  • Studied clinical dose range: 1000000000–100000000000 CFU
  • NIH Office of Dietary Supplements, "Probiotics - Health Professional Fact Sheet": successful clinical outcomes reported across roughly 10^7-10^11 CFU/day depending on strain and indication, with no single dose established as effective/necessary across probiotics generally.
  • Note: Probiotics deliberately do NOT use the compound+forms model applied elsewhere: individual DSLD ingredient rows are species/strain names, aggregated here under one "probiotics" compound by total CFU. Genus/species-level quality tiering is NOT applied -- probiotic efficacy evidence is strain-specific (e.g. a named, clinically- studied strain like GG, BB-12, HN019, DSM 17938 vs. an uncharacterized isolate of the same species), not a property of the genus or even species as a whole; a genus-level tier would misrepresent the science. forms.yaml has no entries for this compound. Alias list includes both pre- and post-2020 Lactobacillus genus-split names (the 2020 taxonomic split created 25 new genera, e.g. Lacticaseibacillus, Lactiplantibacillus) so older and newer label conventions for the same organism aren't fragmented into different rows.
Advertisement